Global Therapeutic Recombinant Protein Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Therapeutic Recombinant Protein market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Therapeutic Recombinant Protein is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Therapeutic Recombinant Protein is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Therapeutic Recombinant Protein is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Therapeutic Recombinant Protein players cover Abcam, HALIX, Avantor, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Techne Corporation, Merck, ACROBiosystems and Abnova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.
LPI (LP Information)' newest research report, the “Therapeutic Recombinant Protein Industry Forecast” looks at past sales and reviews total world Therapeutic Recombinant Protein sales in 2022, providing a comprehensive analysis by region and market sector of projected Therapeutic Recombinant Protein sales for 2023 through 2029. With Therapeutic Recombinant Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Recombinant Protein industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Recombinant Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Recombinant Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Recombinant Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Recombinant Protein and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Recombinant Protein.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Recombinant Protein market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Therapeutic Recombinant Protein market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Therapeutic Recombinant Protein is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Therapeutic Recombinant Protein is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Therapeutic Recombinant Protein is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Therapeutic Recombinant Protein players cover Abcam, HALIX, Avantor, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Techne Corporation, Merck, ACROBiosystems and Abnova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.
LPI (LP Information)' newest research report, the “Therapeutic Recombinant Protein Industry Forecast” looks at past sales and reviews total world Therapeutic Recombinant Protein sales in 2022, providing a comprehensive analysis by region and market sector of projected Therapeutic Recombinant Protein sales for 2023 through 2029. With Therapeutic Recombinant Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Recombinant Protein industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Recombinant Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Recombinant Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Recombinant Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Recombinant Protein and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Recombinant Protein.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Recombinant Protein market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Hormones
- Blood Clotting Factors
- Cytokines
- Enzymes
- Fusion Proteins
- Others
- Pharmaceutical Company
- Research Institute
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abcam
- HALIX
- Avantor
- Miltenyi Biotec
- Thermo Fisher Scientific
- Bio-Techne Corporation
- Merck
- ACROBiosystems
- Abnova
- Eurogentec (Kaneka Corporation)
- Cytiva (Danaher )
- Reprocell
- GenScript
- BPS Bioscience
- Sino Biological
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Recombinant Protein Market Size 2018-2029
2.1.2 Therapeutic Recombinant Protein Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Therapeutic Recombinant Protein Segment by Type
2.2.1 Hormones
2.2.2 Blood Clotting Factors
2.2.3 Cytokines
2.2.4 Enzymes
2.2.5 Fusion Proteins
2.2.6 Others
2.3 Therapeutic Recombinant Protein Market Size by Type
2.3.1 Therapeutic Recombinant Protein Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
2.4 Therapeutic Recombinant Protein Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Research Institute
2.4.3 Others
2.5 Therapeutic Recombinant Protein Market Size by Application
2.5.1 Therapeutic Recombinant Protein Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
3 THERAPEUTIC RECOMBINANT PROTEIN MARKET SIZE BY PLAYER
3.1 Therapeutic Recombinant Protein Market Size Market Share by Players
3.1.1 Global Therapeutic Recombinant Protein Revenue by Players (2018-2023)
3.1.2 Global Therapeutic Recombinant Protein Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Recombinant Protein Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 THERAPEUTIC RECOMBINANT PROTEIN BY REGIONS
4.1 Therapeutic Recombinant Protein Market Size by Regions (2018-2023)
4.2 Americas Therapeutic Recombinant Protein Market Size Growth (2018-2023)
4.3 APAC Therapeutic Recombinant Protein Market Size Growth (2018-2023)
4.4 Europe Therapeutic Recombinant Protein Market Size Growth (2018-2023)
4.5 Middle East & Africa Therapeutic Recombinant Protein Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Therapeutic Recombinant Protein Market Size by Country (2018-2023)
5.2 Americas Therapeutic Recombinant Protein Market Size by Type (2018-2023)
5.3 Americas Therapeutic Recombinant Protein Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Recombinant Protein Market Size by Region (2018-2023)
6.2 APAC Therapeutic Recombinant Protein Market Size by Type (2018-2023)
6.3 APAC Therapeutic Recombinant Protein Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Therapeutic Recombinant Protein by Country (2018-2023)
7.2 Europe Therapeutic Recombinant Protein Market Size by Type (2018-2023)
7.3 Europe Therapeutic Recombinant Protein Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Recombinant Protein by Region (2018-2023)
8.2 Middle East & Africa Therapeutic Recombinant Protein Market Size by Type (2018-2023)
8.3 Middle East & Africa Therapeutic Recombinant Protein Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL THERAPEUTIC RECOMBINANT PROTEIN MARKET FORECAST
10.1 Global Therapeutic Recombinant Protein Forecast by Regions (2024-2029)
10.1.1 Global Therapeutic Recombinant Protein Forecast by Regions (2024-2029)
10.1.2 Americas Therapeutic Recombinant Protein Forecast
10.1.3 APAC Therapeutic Recombinant Protein Forecast
10.1.4 Europe Therapeutic Recombinant Protein Forecast
10.1.5 Middle East & Africa Therapeutic Recombinant Protein Forecast
10.2 Americas Therapeutic Recombinant Protein Forecast by Country (2024-2029)
10.2.1 United States Therapeutic Recombinant Protein Market Forecast
10.2.2 Canada Therapeutic Recombinant Protein Market Forecast
10.2.3 Mexico Therapeutic Recombinant Protein Market Forecast
10.2.4 Brazil Therapeutic Recombinant Protein Market Forecast
10.3 APAC Therapeutic Recombinant Protein Forecast by Region (2024-2029)
10.3.1 China Therapeutic Recombinant Protein Market Forecast
10.3.2 Japan Therapeutic Recombinant Protein Market Forecast
10.3.3 Korea Therapeutic Recombinant Protein Market Forecast
10.3.4 Southeast Asia Therapeutic Recombinant Protein Market Forecast
10.3.5 India Therapeutic Recombinant Protein Market Forecast
10.3.6 Australia Therapeutic Recombinant Protein Market Forecast
10.4 Europe Therapeutic Recombinant Protein Forecast by Country (2024-2029)
10.4.1 Germany Therapeutic Recombinant Protein Market Forecast
10.4.2 France Therapeutic Recombinant Protein Market Forecast
10.4.3 UK Therapeutic Recombinant Protein Market Forecast
10.4.4 Italy Therapeutic Recombinant Protein Market Forecast
10.4.5 Russia Therapeutic Recombinant Protein Market Forecast
10.5 Middle East & Africa Therapeutic Recombinant Protein Forecast by Region (2024-2029)
10.5.1 Egypt Therapeutic Recombinant Protein Market Forecast
10.5.2 South Africa Therapeutic Recombinant Protein Market Forecast
10.5.3 Israel Therapeutic Recombinant Protein Market Forecast
10.5.4 Turkey Therapeutic Recombinant Protein Market Forecast
10.5.5 GCC Countries Therapeutic Recombinant Protein Market Forecast
10.6 Global Therapeutic Recombinant Protein Forecast by Type (2024-2029)
10.7 Global Therapeutic Recombinant Protein Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abcam
11.1.1 Abcam Company Information
11.1.2 Abcam Therapeutic Recombinant Protein Product Offered
11.1.3 Abcam Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abcam Main Business Overview
11.1.5 Abcam Latest Developments
11.2 HALIX
11.2.1 HALIX Company Information
11.2.2 HALIX Therapeutic Recombinant Protein Product Offered
11.2.3 HALIX Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 HALIX Main Business Overview
11.2.5 HALIX Latest Developments
11.3 Avantor
11.3.1 Avantor Company Information
11.3.2 Avantor Therapeutic Recombinant Protein Product Offered
11.3.3 Avantor Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Avantor Main Business Overview
11.3.5 Avantor Latest Developments
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Information
11.4.2 Miltenyi Biotec Therapeutic Recombinant Protein Product Offered
11.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Miltenyi Biotec Main Business Overview
11.4.5 Miltenyi Biotec Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific Therapeutic Recombinant Protein Product Offered
11.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Bio-Techne Corporation
11.6.1 Bio-Techne Corporation Company Information
11.6.2 Bio-Techne Corporation Therapeutic Recombinant Protein Product Offered
11.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bio-Techne Corporation Main Business Overview
11.6.5 Bio-Techne Corporation Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Therapeutic Recombinant Protein Product Offered
11.7.3 Merck Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 ACROBiosystems
11.8.1 ACROBiosystems Company Information
11.8.2 ACROBiosystems Therapeutic Recombinant Protein Product Offered
11.8.3 ACROBiosystems Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 ACROBiosystems Main Business Overview
11.8.5 ACROBiosystems Latest Developments
11.9 Abnova
11.9.1 Abnova Company Information
11.9.2 Abnova Therapeutic Recombinant Protein Product Offered
11.9.3 Abnova Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Abnova Main Business Overview
11.9.5 Abnova Latest Developments
11.10 Eurogentec (Kaneka Corporation)
11.10.1 Eurogentec (Kaneka Corporation) Company Information
11.10.2 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product Offered
11.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eurogentec (Kaneka Corporation) Main Business Overview
11.10.5 Eurogentec (Kaneka Corporation) Latest Developments
11.11 Cytiva (Danaher )
11.11.1 Cytiva (Danaher ) Company Information
11.11.2 Cytiva (Danaher ) Therapeutic Recombinant Protein Product Offered
11.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cytiva (Danaher ) Main Business Overview
11.11.5 Cytiva (Danaher ) Latest Developments
11.12 Reprocell
11.12.1 Reprocell Company Information
11.12.2 Reprocell Therapeutic Recombinant Protein Product Offered
11.12.3 Reprocell Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Reprocell Main Business Overview
11.12.5 Reprocell Latest Developments
11.13 GenScript
11.13.1 GenScript Company Information
11.13.2 GenScript Therapeutic Recombinant Protein Product Offered
11.13.3 GenScript Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 GenScript Main Business Overview
11.13.5 GenScript Latest Developments
11.14 BPS Bioscience
11.14.1 BPS Bioscience Company Information
11.14.2 BPS Bioscience Therapeutic Recombinant Protein Product Offered
11.14.3 BPS Bioscience Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 BPS Bioscience Main Business Overview
11.14.5 BPS Bioscience Latest Developments
11.15 Sino Biological
11.15.1 Sino Biological Company Information
11.15.2 Sino Biological Therapeutic Recombinant Protein Product Offered
11.15.3 Sino Biological Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sino Biological Main Business Overview
11.15.5 Sino Biological Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Recombinant Protein Market Size 2018-2029
2.1.2 Therapeutic Recombinant Protein Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Therapeutic Recombinant Protein Segment by Type
2.2.1 Hormones
2.2.2 Blood Clotting Factors
2.2.3 Cytokines
2.2.4 Enzymes
2.2.5 Fusion Proteins
2.2.6 Others
2.3 Therapeutic Recombinant Protein Market Size by Type
2.3.1 Therapeutic Recombinant Protein Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
2.4 Therapeutic Recombinant Protein Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Research Institute
2.4.3 Others
2.5 Therapeutic Recombinant Protein Market Size by Application
2.5.1 Therapeutic Recombinant Protein Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
3 THERAPEUTIC RECOMBINANT PROTEIN MARKET SIZE BY PLAYER
3.1 Therapeutic Recombinant Protein Market Size Market Share by Players
3.1.1 Global Therapeutic Recombinant Protein Revenue by Players (2018-2023)
3.1.2 Global Therapeutic Recombinant Protein Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Recombinant Protein Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 THERAPEUTIC RECOMBINANT PROTEIN BY REGIONS
4.1 Therapeutic Recombinant Protein Market Size by Regions (2018-2023)
4.2 Americas Therapeutic Recombinant Protein Market Size Growth (2018-2023)
4.3 APAC Therapeutic Recombinant Protein Market Size Growth (2018-2023)
4.4 Europe Therapeutic Recombinant Protein Market Size Growth (2018-2023)
4.5 Middle East & Africa Therapeutic Recombinant Protein Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Therapeutic Recombinant Protein Market Size by Country (2018-2023)
5.2 Americas Therapeutic Recombinant Protein Market Size by Type (2018-2023)
5.3 Americas Therapeutic Recombinant Protein Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Recombinant Protein Market Size by Region (2018-2023)
6.2 APAC Therapeutic Recombinant Protein Market Size by Type (2018-2023)
6.3 APAC Therapeutic Recombinant Protein Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Therapeutic Recombinant Protein by Country (2018-2023)
7.2 Europe Therapeutic Recombinant Protein Market Size by Type (2018-2023)
7.3 Europe Therapeutic Recombinant Protein Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Recombinant Protein by Region (2018-2023)
8.2 Middle East & Africa Therapeutic Recombinant Protein Market Size by Type (2018-2023)
8.3 Middle East & Africa Therapeutic Recombinant Protein Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL THERAPEUTIC RECOMBINANT PROTEIN MARKET FORECAST
10.1 Global Therapeutic Recombinant Protein Forecast by Regions (2024-2029)
10.1.1 Global Therapeutic Recombinant Protein Forecast by Regions (2024-2029)
10.1.2 Americas Therapeutic Recombinant Protein Forecast
10.1.3 APAC Therapeutic Recombinant Protein Forecast
10.1.4 Europe Therapeutic Recombinant Protein Forecast
10.1.5 Middle East & Africa Therapeutic Recombinant Protein Forecast
10.2 Americas Therapeutic Recombinant Protein Forecast by Country (2024-2029)
10.2.1 United States Therapeutic Recombinant Protein Market Forecast
10.2.2 Canada Therapeutic Recombinant Protein Market Forecast
10.2.3 Mexico Therapeutic Recombinant Protein Market Forecast
10.2.4 Brazil Therapeutic Recombinant Protein Market Forecast
10.3 APAC Therapeutic Recombinant Protein Forecast by Region (2024-2029)
10.3.1 China Therapeutic Recombinant Protein Market Forecast
10.3.2 Japan Therapeutic Recombinant Protein Market Forecast
10.3.3 Korea Therapeutic Recombinant Protein Market Forecast
10.3.4 Southeast Asia Therapeutic Recombinant Protein Market Forecast
10.3.5 India Therapeutic Recombinant Protein Market Forecast
10.3.6 Australia Therapeutic Recombinant Protein Market Forecast
10.4 Europe Therapeutic Recombinant Protein Forecast by Country (2024-2029)
10.4.1 Germany Therapeutic Recombinant Protein Market Forecast
10.4.2 France Therapeutic Recombinant Protein Market Forecast
10.4.3 UK Therapeutic Recombinant Protein Market Forecast
10.4.4 Italy Therapeutic Recombinant Protein Market Forecast
10.4.5 Russia Therapeutic Recombinant Protein Market Forecast
10.5 Middle East & Africa Therapeutic Recombinant Protein Forecast by Region (2024-2029)
10.5.1 Egypt Therapeutic Recombinant Protein Market Forecast
10.5.2 South Africa Therapeutic Recombinant Protein Market Forecast
10.5.3 Israel Therapeutic Recombinant Protein Market Forecast
10.5.4 Turkey Therapeutic Recombinant Protein Market Forecast
10.5.5 GCC Countries Therapeutic Recombinant Protein Market Forecast
10.6 Global Therapeutic Recombinant Protein Forecast by Type (2024-2029)
10.7 Global Therapeutic Recombinant Protein Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abcam
11.1.1 Abcam Company Information
11.1.2 Abcam Therapeutic Recombinant Protein Product Offered
11.1.3 Abcam Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abcam Main Business Overview
11.1.5 Abcam Latest Developments
11.2 HALIX
11.2.1 HALIX Company Information
11.2.2 HALIX Therapeutic Recombinant Protein Product Offered
11.2.3 HALIX Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 HALIX Main Business Overview
11.2.5 HALIX Latest Developments
11.3 Avantor
11.3.1 Avantor Company Information
11.3.2 Avantor Therapeutic Recombinant Protein Product Offered
11.3.3 Avantor Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Avantor Main Business Overview
11.3.5 Avantor Latest Developments
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Information
11.4.2 Miltenyi Biotec Therapeutic Recombinant Protein Product Offered
11.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Miltenyi Biotec Main Business Overview
11.4.5 Miltenyi Biotec Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific Therapeutic Recombinant Protein Product Offered
11.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Bio-Techne Corporation
11.6.1 Bio-Techne Corporation Company Information
11.6.2 Bio-Techne Corporation Therapeutic Recombinant Protein Product Offered
11.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bio-Techne Corporation Main Business Overview
11.6.5 Bio-Techne Corporation Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Therapeutic Recombinant Protein Product Offered
11.7.3 Merck Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 ACROBiosystems
11.8.1 ACROBiosystems Company Information
11.8.2 ACROBiosystems Therapeutic Recombinant Protein Product Offered
11.8.3 ACROBiosystems Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 ACROBiosystems Main Business Overview
11.8.5 ACROBiosystems Latest Developments
11.9 Abnova
11.9.1 Abnova Company Information
11.9.2 Abnova Therapeutic Recombinant Protein Product Offered
11.9.3 Abnova Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Abnova Main Business Overview
11.9.5 Abnova Latest Developments
11.10 Eurogentec (Kaneka Corporation)
11.10.1 Eurogentec (Kaneka Corporation) Company Information
11.10.2 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product Offered
11.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eurogentec (Kaneka Corporation) Main Business Overview
11.10.5 Eurogentec (Kaneka Corporation) Latest Developments
11.11 Cytiva (Danaher )
11.11.1 Cytiva (Danaher ) Company Information
11.11.2 Cytiva (Danaher ) Therapeutic Recombinant Protein Product Offered
11.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cytiva (Danaher ) Main Business Overview
11.11.5 Cytiva (Danaher ) Latest Developments
11.12 Reprocell
11.12.1 Reprocell Company Information
11.12.2 Reprocell Therapeutic Recombinant Protein Product Offered
11.12.3 Reprocell Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Reprocell Main Business Overview
11.12.5 Reprocell Latest Developments
11.13 GenScript
11.13.1 GenScript Company Information
11.13.2 GenScript Therapeutic Recombinant Protein Product Offered
11.13.3 GenScript Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 GenScript Main Business Overview
11.13.5 GenScript Latest Developments
11.14 BPS Bioscience
11.14.1 BPS Bioscience Company Information
11.14.2 BPS Bioscience Therapeutic Recombinant Protein Product Offered
11.14.3 BPS Bioscience Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 BPS Bioscience Main Business Overview
11.14.5 BPS Bioscience Latest Developments
11.15 Sino Biological
11.15.1 Sino Biological Company Information
11.15.2 Sino Biological Therapeutic Recombinant Protein Product Offered
11.15.3 Sino Biological Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sino Biological Main Business Overview
11.15.5 Sino Biological Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Therapeutic Recombinant Protein Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hormones
Table 3. Major Players of Blood Clotting Factors
Table 4. Major Players of Cytokines
Table 5. Major Players of Enzymes
Table 6. Major Players of Fusion Proteins
Table 7. Major Players of Others
Table 8. Therapeutic Recombinant Protein Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 11. Therapeutic Recombinant Protein Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 14. Global Therapeutic Recombinant Protein Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Therapeutic Recombinant Protein Revenue Market Share by Player (2018-2023)
Table 16. Therapeutic Recombinant Protein Key Players Head office and Products Offered
Table 17. Therapeutic Recombinant Protein Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Therapeutic Recombinant Protein Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Therapeutic Recombinant Protein Market Size Market Share by Regions (2018-2023)
Table 22. Global Therapeutic Recombinant Protein Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Therapeutic Recombinant Protein Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Therapeutic Recombinant Protein Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Therapeutic Recombinant Protein Market Size Market Share by Country (2018-2023)
Table 26. Americas Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 28. Americas Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 30. APAC Therapeutic Recombinant Protein Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Therapeutic Recombinant Protein Market Size Market Share by Region (2018-2023)
Table 32. APAC Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 34. APAC Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 36. Europe Therapeutic Recombinant Protein Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Therapeutic Recombinant Protein Market Size Market Share by Country (2018-2023)
Table 38. Europe Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 40. Europe Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Therapeutic Recombinant Protein Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Therapeutic Recombinant Protein
Table 49. Key Market Challenges & Risks of Therapeutic Recombinant Protein
Table 50. Key Industry Trends of Therapeutic Recombinant Protein
Table 51. Global Therapeutic Recombinant Protein Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Therapeutic Recombinant Protein Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Therapeutic Recombinant Protein Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Therapeutic Recombinant Protein Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. Abcam Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 56. Abcam Therapeutic Recombinant Protein Product Offered
Table 57. Abcam Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. Abcam Main Business
Table 59. Abcam Latest Developments
Table 60. HALIX Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 61. HALIX Therapeutic Recombinant Protein Product Offered
Table 62. HALIX Main Business
Table 63. HALIX Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. HALIX Latest Developments
Table 65. Avantor Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 66. Avantor Therapeutic Recombinant Protein Product Offered
Table 67. Avantor Main Business
Table 68. Avantor Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Avantor Latest Developments
Table 70. Miltenyi Biotec Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 71. Miltenyi Biotec Therapeutic Recombinant Protein Product Offered
Table 72. Miltenyi Biotec Main Business
Table 73. Miltenyi Biotec Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. Miltenyi Biotec Latest Developments
Table 75. Thermo Fisher Scientific Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 76. Thermo Fisher Scientific Therapeutic Recombinant Protein Product Offered
Table 77. Thermo Fisher Scientific Main Business
Table 78. Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Latest Developments
Table 80. Bio-Techne Corporation Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 81. Bio-Techne Corporation Therapeutic Recombinant Protein Product Offered
Table 82. Bio-Techne Corporation Main Business
Table 83. Bio-Techne Corporation Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Bio-Techne Corporation Latest Developments
Table 85. Merck Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 86. Merck Therapeutic Recombinant Protein Product Offered
Table 87. Merck Main Business
Table 88. Merck Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. Merck Latest Developments
Table 90. ACROBiosystems Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 91. ACROBiosystems Therapeutic Recombinant Protein Product Offered
Table 92. ACROBiosystems Main Business
Table 93. ACROBiosystems Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. ACROBiosystems Latest Developments
Table 95. Abnova Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 96. Abnova Therapeutic Recombinant Protein Product Offered
Table 97. Abnova Main Business
Table 98. Abnova Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 99. Abnova Latest Developments
Table 100. Eurogentec (Kaneka Corporation) Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 101. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product Offered
Table 102. Eurogentec (Kaneka Corporation) Main Business
Table 103. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Eurogentec (Kaneka Corporation) Latest Developments
Table 105. Cytiva (Danaher ) Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 106. Cytiva (Danaher ) Therapeutic Recombinant Protein Product Offered
Table 107. Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 108. Cytiva (Danaher ) Main Business
Table 109. Cytiva (Danaher ) Latest Developments
Table 110. Reprocell Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 111. Reprocell Therapeutic Recombinant Protein Product Offered
Table 112. Reprocell Main Business
Table 113. Reprocell Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 114. Reprocell Latest Developments
Table 115. GenScript Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 116. GenScript Therapeutic Recombinant Protein Product Offered
Table 117. GenScript Main Business
Table 118. GenScript Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 119. GenScript Latest Developments
Table 120. BPS Bioscience Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 121. BPS Bioscience Therapeutic Recombinant Protein Product Offered
Table 122. BPS Bioscience Main Business
Table 123. BPS Bioscience Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 124. BPS Bioscience Latest Developments
Table 125. Sino Biological Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 126. Sino Biological Therapeutic Recombinant Protein Product Offered
Table 127. Sino Biological Main Business
Table 128. Sino Biological Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 129. Sino Biological Latest Developments
Table 1. Therapeutic Recombinant Protein Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hormones
Table 3. Major Players of Blood Clotting Factors
Table 4. Major Players of Cytokines
Table 5. Major Players of Enzymes
Table 6. Major Players of Fusion Proteins
Table 7. Major Players of Others
Table 8. Therapeutic Recombinant Protein Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 11. Therapeutic Recombinant Protein Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 14. Global Therapeutic Recombinant Protein Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Therapeutic Recombinant Protein Revenue Market Share by Player (2018-2023)
Table 16. Therapeutic Recombinant Protein Key Players Head office and Products Offered
Table 17. Therapeutic Recombinant Protein Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Therapeutic Recombinant Protein Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Therapeutic Recombinant Protein Market Size Market Share by Regions (2018-2023)
Table 22. Global Therapeutic Recombinant Protein Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Therapeutic Recombinant Protein Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Therapeutic Recombinant Protein Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Therapeutic Recombinant Protein Market Size Market Share by Country (2018-2023)
Table 26. Americas Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 28. Americas Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 30. APAC Therapeutic Recombinant Protein Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Therapeutic Recombinant Protein Market Size Market Share by Region (2018-2023)
Table 32. APAC Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 34. APAC Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 36. Europe Therapeutic Recombinant Protein Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Therapeutic Recombinant Protein Market Size Market Share by Country (2018-2023)
Table 38. Europe Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 40. Europe Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Therapeutic Recombinant Protein Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Therapeutic Recombinant Protein Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Therapeutic Recombinant Protein Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Therapeutic Recombinant Protein
Table 49. Key Market Challenges & Risks of Therapeutic Recombinant Protein
Table 50. Key Industry Trends of Therapeutic Recombinant Protein
Table 51. Global Therapeutic Recombinant Protein Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Therapeutic Recombinant Protein Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Therapeutic Recombinant Protein Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Therapeutic Recombinant Protein Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. Abcam Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 56. Abcam Therapeutic Recombinant Protein Product Offered
Table 57. Abcam Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. Abcam Main Business
Table 59. Abcam Latest Developments
Table 60. HALIX Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 61. HALIX Therapeutic Recombinant Protein Product Offered
Table 62. HALIX Main Business
Table 63. HALIX Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. HALIX Latest Developments
Table 65. Avantor Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 66. Avantor Therapeutic Recombinant Protein Product Offered
Table 67. Avantor Main Business
Table 68. Avantor Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Avantor Latest Developments
Table 70. Miltenyi Biotec Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 71. Miltenyi Biotec Therapeutic Recombinant Protein Product Offered
Table 72. Miltenyi Biotec Main Business
Table 73. Miltenyi Biotec Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. Miltenyi Biotec Latest Developments
Table 75. Thermo Fisher Scientific Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 76. Thermo Fisher Scientific Therapeutic Recombinant Protein Product Offered
Table 77. Thermo Fisher Scientific Main Business
Table 78. Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Latest Developments
Table 80. Bio-Techne Corporation Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 81. Bio-Techne Corporation Therapeutic Recombinant Protein Product Offered
Table 82. Bio-Techne Corporation Main Business
Table 83. Bio-Techne Corporation Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Bio-Techne Corporation Latest Developments
Table 85. Merck Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 86. Merck Therapeutic Recombinant Protein Product Offered
Table 87. Merck Main Business
Table 88. Merck Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. Merck Latest Developments
Table 90. ACROBiosystems Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 91. ACROBiosystems Therapeutic Recombinant Protein Product Offered
Table 92. ACROBiosystems Main Business
Table 93. ACROBiosystems Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. ACROBiosystems Latest Developments
Table 95. Abnova Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 96. Abnova Therapeutic Recombinant Protein Product Offered
Table 97. Abnova Main Business
Table 98. Abnova Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 99. Abnova Latest Developments
Table 100. Eurogentec (Kaneka Corporation) Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 101. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product Offered
Table 102. Eurogentec (Kaneka Corporation) Main Business
Table 103. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Eurogentec (Kaneka Corporation) Latest Developments
Table 105. Cytiva (Danaher ) Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 106. Cytiva (Danaher ) Therapeutic Recombinant Protein Product Offered
Table 107. Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 108. Cytiva (Danaher ) Main Business
Table 109. Cytiva (Danaher ) Latest Developments
Table 110. Reprocell Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 111. Reprocell Therapeutic Recombinant Protein Product Offered
Table 112. Reprocell Main Business
Table 113. Reprocell Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 114. Reprocell Latest Developments
Table 115. GenScript Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 116. GenScript Therapeutic Recombinant Protein Product Offered
Table 117. GenScript Main Business
Table 118. GenScript Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 119. GenScript Latest Developments
Table 120. BPS Bioscience Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 121. BPS Bioscience Therapeutic Recombinant Protein Product Offered
Table 122. BPS Bioscience Main Business
Table 123. BPS Bioscience Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 124. BPS Bioscience Latest Developments
Table 125. Sino Biological Details, Company Type, Therapeutic Recombinant Protein Area Served and Its Competitors
Table 126. Sino Biological Therapeutic Recombinant Protein Product Offered
Table 127. Sino Biological Main Business
Table 128. Sino Biological Therapeutic Recombinant Protein Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 129. Sino Biological Latest Developments
LIST OF FIGURES
Figure 1. Therapeutic Recombinant Protein Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Therapeutic Recombinant Protein Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Therapeutic Recombinant Protein Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Therapeutic Recombinant Protein Sales Market Share by Country/Region (2022)
Figure 8. Therapeutic Recombinant Protein Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Therapeutic Recombinant Protein Market Size Market Share by Type in 2022
Figure 10. Therapeutic Recombinant Protein in Pharmaceutical Company
Figure 11. Global Therapeutic Recombinant Protein Market: Pharmaceutical Company (2018-2023) & ($ Millions)
Figure 12. Therapeutic Recombinant Protein in Research Institute
Figure 13. Global Therapeutic Recombinant Protein Market: Research Institute (2018-2023) & ($ Millions)
Figure 14. Therapeutic Recombinant Protein in Others
Figure 15. Global Therapeutic Recombinant Protein Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Therapeutic Recombinant Protein Market Size Market Share by Application in 2022
Figure 17. Global Therapeutic Recombinant Protein Revenue Market Share by Player in 2022
Figure 18. Global Therapeutic Recombinant Protein Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 20. APAC Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 21. Europe Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 23. Americas Therapeutic Recombinant Protein Value Market Share by Country in 2022
Figure 24. United States Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Therapeutic Recombinant Protein Market Size Market Share by Region in 2022
Figure 29. APAC Therapeutic Recombinant Protein Market Size Market Share by Type in 2022
Figure 30. APAC Therapeutic Recombinant Protein Market Size Market Share by Application in 2022
Figure 31. China Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Therapeutic Recombinant Protein Market Size Market Share by Country in 2022
Figure 38. Europe Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Figure 39. Europe Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Figure 40. Germany Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 54. APAC Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 55. Europe Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 57. United States Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 58. Canada Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 61. China Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 62. Japan Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 63. Korea Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 65. India Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 66. Australia Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 67. Germany Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 68. France Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 69. UK Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 70. Italy Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 71. Russia Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 72. Spain Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 75. Israel Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 78. Global Therapeutic Recombinant Protein Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Therapeutic Recombinant Protein Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Therapeutic Recombinant Protein Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Therapeutic Recombinant Protein Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Therapeutic Recombinant Protein Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Therapeutic Recombinant Protein Sales Market Share by Country/Region (2022)
Figure 8. Therapeutic Recombinant Protein Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Therapeutic Recombinant Protein Market Size Market Share by Type in 2022
Figure 10. Therapeutic Recombinant Protein in Pharmaceutical Company
Figure 11. Global Therapeutic Recombinant Protein Market: Pharmaceutical Company (2018-2023) & ($ Millions)
Figure 12. Therapeutic Recombinant Protein in Research Institute
Figure 13. Global Therapeutic Recombinant Protein Market: Research Institute (2018-2023) & ($ Millions)
Figure 14. Therapeutic Recombinant Protein in Others
Figure 15. Global Therapeutic Recombinant Protein Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Therapeutic Recombinant Protein Market Size Market Share by Application in 2022
Figure 17. Global Therapeutic Recombinant Protein Revenue Market Share by Player in 2022
Figure 18. Global Therapeutic Recombinant Protein Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 20. APAC Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 21. Europe Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Therapeutic Recombinant Protein Market Size 2018-2023 ($ Millions)
Figure 23. Americas Therapeutic Recombinant Protein Value Market Share by Country in 2022
Figure 24. United States Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Therapeutic Recombinant Protein Market Size Market Share by Region in 2022
Figure 29. APAC Therapeutic Recombinant Protein Market Size Market Share by Type in 2022
Figure 30. APAC Therapeutic Recombinant Protein Market Size Market Share by Application in 2022
Figure 31. China Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Therapeutic Recombinant Protein Market Size Market Share by Country in 2022
Figure 38. Europe Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Figure 39. Europe Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Figure 40. Germany Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Therapeutic Recombinant Protein Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Therapeutic Recombinant Protein Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 54. APAC Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 55. Europe Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 57. United States Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 58. Canada Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 61. China Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 62. Japan Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 63. Korea Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 65. India Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 66. Australia Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 67. Germany Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 68. France Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 69. UK Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 70. Italy Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 71. Russia Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 72. Spain Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 75. Israel Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Therapeutic Recombinant Protein Market Size 2024-2029 ($ Millions)
Figure 78. Global Therapeutic Recombinant Protein Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Therapeutic Recombinant Protein Market Size Market Share Forecast by Application (2024-2029)
